The invention concerns genes and fusion of genes that code for scorpion
toxins and the corresponding polypeptides. The invention also concerns
the use of the polypeptides as immunogens for the generation of
antibodies that can recognize and neutralize components of scorpion venom
as well as for vaccines to prevent envenomation from stings of scorpions
of the genus Centruroides, and to immunogenic matrices for the
purification of specific immunoglobulins.